Back to search results

MSC EVs in Dystrophic Epidermolysis Bullosa

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Dystrophic Epidermolysis Bullosa

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Phoenix Children's Hospital, Phoenix, Arizona, United States

    Contact: Study coordinator (Kellie Badger, BS, RN) · kbadger@phoenixchildres.com · 602-933-2053
    Contact: Principal Investigator (Harper N Price, MD, FAAD, FAAP)

  • USC /Norris Comprehensive Cancer Center University of Southern California, Los Angeles, California, United States

    Contact: Study coordinator (Mei Chen, PhD) · chenm@usc.edu · 323-865-0621
    Contact: Principal Investigator (David Woodley, MD)

  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Griffin S Hogrogian, MSEd) · stocktonhg@chop.edu · 215-590-1930
    Contact: Principal Investigator (Marissa Perman, MD)
Study leads

  • David T Woodley, MD

    Principal Investigator

    University of Southern California Dept of Dermatology

View source on ClinicalTrials.gov(opens in a new tab)